International Patient Engagement Intern
Vertex Pharmaceuticals
International Patient Engagement Intern
Vertex Pharmaceuticals
Develops therapies for serious genetic diseases
Job Description
International Patient Engagement - Industrial Placement 12 Months
Paddington, London UK
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, MA, Vertex today has research and development sites and commercial offices around the world in the United States, Canada, Europe and Australia.
Vertex is looking for enthusiastic, curious and dedicated students to join our International Patient Engagement (IPE) team for a one-year industrial placement. This based position is located at our International HQ based at Paddington, London. Applicants should be undertaking a relevant degree qualification and ideally have a strong interest in patient engagement in the Biotech/Pharmaceutical industry.
Role Description
The IPE team is responsible for bringing the patients’ perspective into Vertex’s work by establishing meaningful collaborations with patient communities at in-country and above-country level. IPE works across the whole lifecycle of therapies and medicines developed by Vertex. By joining IPE, you will learn how Vertex engages externally and how such engagement shapes decisions across the whole lifecycle of Vertex’s medicines and therapies, from early research to post-marketing.
During Industrial Placements you will get the opportunity to learn about our industry from a hands-on perspective. You will be working closely with and learning from some of the brightest people in the industry. Students can expect to be challenged by their work, connect with other students, and feel valued by the Vertex community.
Person Specification
Role Duration
September 2027 to August 2028
Our Ways of Working:
Flex @ Vertex details
Flex Designation: Hybrid-Eligible Or On-Site Eligible
Flex Eligibility Status
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
At Vertex, we embrace continuous learning and encourage employees to stay informed on advances in AI, technology, automation, and industry trends. We seek talent who bring an external perspective, demonstrate curiosity and sound judgment, and thoughtfully adopt new capabilities that improve decision-making, drive innovation, increase efficiency, and help deliver better outcomes for patients.
Flex Designation:
Hybrid-Eligible Or On-Site EligibleFlex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
#LI-Hybrid
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]
Develops therapies for serious genetic diseases
Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.
Explore more opportunities at Vertex Pharmaceuticals